source
- Medicare's new add-on payments for AI devices may spur hospital adoption and risk overuseMedicare has begun paying hospitals extra fees for using newly authorized AI-based medical devices, known as technology add-on payments, for a limited period after market entry. The payments are i…
- PTC Therapeutics acquires Sangamo’s Fabry gene therapy program for $111 million upfrontPTC Therapeutics announced it has purchased the Fabry disease gene-therapy program (ST-920) from Sangamo Therapeutics. The deal provides $111 million in upfront cash and includes up to $100 millio…